Comparison of functional and nonfunctional neuroendocrine tumors in the pancreas and peripancreatic region

Pancreas

Volumn 40, Issue 2, 2011, Pages 253-259

  Wang, Shin E ^a   Su, Cheng Hsi ^a   Kuo, Ying Ju ^a   Shyr, Yi Ming ^a   Li, Anna Fen Yau ^a   Chen, Tien Hua ^a   Wu, Chew Wun ^a   Lee, Chen Hsen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

functional; neuroendocrine tumor; nonfunctional; pancreas; peripancreatic; respectability

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; BACKACHE; CANCER STAGING; CANCER SURGERY; CHILD; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DISEASE FREE SURVIVAL; EVALUATION AND FOLLOW UP; FEMALE; FUNCTIONAL NEUROENDOCRINE TUMOR; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; JAUNDICE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NEUROENDOCRINE TUMOR; NONFUNCTIONAL NEUROENDOCRINE TUMOR; PANCREAS; PANCREAS CARCINOMA; PANCREAS TUMOR; PEPTIC ULCER; PERIPANCREATIC REGION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVARIATE ANALYSIS; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; CHILD; DISEASE-FREE SURVIVAL; FEMALE; GASTRINS; GASTROINTESTINAL HORMONES; GLUCAGON; HUMANS; INSULIN; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; ODDS RATIO; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; VASOACTIVE INTESTINAL PEPTIDE; YOUNG ADULT;

EID: 79951724286     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181f94cc4     Document Type: Article

References (27)

1. Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg. 2008;95:627-635.
2. Oberndorfer S. Karzinoide Tumoren des Dunndarms. Frankfurt Ztschr Pathol. 1907;1:426-432.
3. Arnold R, Goke R, Wied M, et al. Neuroendocrine gastroenteropancreatic tumors. In: Scheppach W, Bresalier RS, Tytgat GN, eds. Gastrointestinal and Liver Tumors. Berlin, Germany: Springer; 2004:195-233.
4. Panzuto F, Nasoni S, Falconi M, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer. 2005;12:1083-1092. (Pubitemid 41815799)
5. Solcia E, Kloppel G, Sobin LH, et al. Histological Typing of Endocrine Tumours (WHO International Histological Classification of Tumours). 2nd ed. Berlin, Germany: Springer; 2000.
6. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13-27. (Pubitemid 38594787)
7. Dixon E, Pasieka JL. Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol. 2007;19:30-35. (Pubitemid 44885597)
8. Bilimoria KY, Tomlinson JS, Merkow RP, et al. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9821 patients. J Gastrointest Surg. 2007;11:1460-1467.
9. Fitzgerald T, Hickner Z, Schmitz M. Increasing Incidence of Nonfunctional Neuroendocrine Tumors of the Pancreas. Orlando, FL: American Society of Clinical Oncology Gastrointestinal Cancers Symposium; 2007.
10. Jensen RT, Norton JA. Endocrine neoplasms of the pancreas. In: Yamada T, ed. Textbook of Gastroenterology. Vol 2. 2nd ed. Philadelphia, PA: JB Lippincott; 2003:2108-2146.
11. Hochwald SN, Conlon KC, Brennan MF. Nonfunctioning pancreatic islet cell tumors. In: Doherty GM, ed. Surgical Endocrinology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:361-373.
12. Kazanjian KK, Reber HA, Hines OJ. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg. 2006;141:765-770.
13. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol. 2002;20:2633-2642. (Pubitemid 34575635)
14. O'Grady HL, Conlon KC. Pancreatic neuroendocrine tumours. Eur J Surg Oncol. 2008;34:324-332. (Pubitemid 351312867)
15. Lo CY, Van Heerden JA, Thompson GB. Islet cell carcinoma of the pancreas. World J Surg. 1996;20:878-884. (Pubitemid 26281918)
16. Chu QD, Hill HC, Douglass HO Jr, et al. Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Ann Surg Oncol. 2002;9:855-862. (Pubitemid 35265635)
17. White TJ, Edney JA, Thompson JS, et al. Is there a prognostic difference between functional and nonfunctional islet cell tumors? Am J Surg. 1994;168:627-630.
18. Phan GQ, Yeo CJ, Hruban RH, et al. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg. 1998;2:473-482. (Pubitemid 128427984)
19. Thompson GB, van Heerden JA, Grant CS, et al. Islet cell carcinoma of the pancreas: a twenty-year experience. Surgery. 1988;104:1011-1017. (Pubitemid 19011980)
20. Schurr PG, Strate T, Rese K, et al. Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg. 2007;245:273-281. (Pubitemid 46148487)
21. Broughan TA, Leslie JD, Soto JM, et al. Pancreatic islet cell tumors. Surgery. 1986;99:671-678. (Pubitemid 16069108)
22. Bieligk S, Jaffe BM. Islet cell tumors of the pancreas. Surg Clin North Am. 1995;75:1025-1040.
23. Jarufe NP, Coldham C, Orug T, et al. Neuroendocrine tumours of the pancreas: predictors of survival after surgical treatment. Dig Surg. 2005;22:157-162. (Pubitemid 41330835)
24. Norton JA, Fraker DL, Alexander HR, et al. Surgery increases survival in patients with gastrinoma. Ann Surg. 2006;244:410-419.
25. Sellner F, Sobhian B, De Santis M, et al. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases. Eur J Surg Oncol. 2008;34:191-195.
26. Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004;198:722-731. (Pubitemid 38542900)
27. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg. 2006;10:1199-1210.